naloxone hydrochloride
Generic: naloxone hydrochloride
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
naloxone hydrochloride
Generic Name
naloxone hydrochloride
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
naloxone hydrochloride .4 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
76045-114
Product ID
76045-114_6503f42d-3303-497a-9653-4b6d89bf7833
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213573
Listing Expiration
2026-12-31
Marketing Start
2024-04-02
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76045114
Hyphenated Format
76045-114
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naloxone hydrochloride (source: ndc)
Generic Name
naloxone hydrochloride (source: ndc)
Application Number
ANDA213573 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .4 mg/mL
Packaging
- 24 SYRINGE in 1 CARTON (76045-114-10) / 1 mL in 1 SYRINGE (76045-114-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "6503f42d-3303-497a-9653-4b6d89bf7833", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1191250", "2679504"], "spl_set_id": ["201fdedf-1736-4e52-9d7d-de14292547fd"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 SYRINGE in 1 CARTON (76045-114-10) / 1 mL in 1 SYRINGE (76045-114-01)", "package_ndc": "76045-114-10", "marketing_start_date": "20240402"}], "brand_name": "Naloxone Hydrochloride", "product_id": "76045-114_6503f42d-3303-497a-9653-4b6d89bf7833", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "76045-114", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA213573", "marketing_category": "ANDA", "marketing_start_date": "20240402", "listing_expiration_date": "20261231"}